The Evidence for Adjuvant Treatment of Elderly Patients (age > or = 70) with Stage III Colon Cancer is Inconclusive

Overview

Journal Surg Today

Specialty General Surgery

Date 2010 Mar 27

PMID 20339997

Citations 2

Authors

Kok-Yang Tan

Fumio Konishi

Koichi Suzuki

Affiliations

Soon will be listed here.

Abstract

This article critically discusses the current evidence for adjuvant chemotherapy in elderly patients (> or =70 years of age) with stage III colon cancer. The authors emphasize that current evidence is inconclusive, and surgeons should be aware of this fact when making informed decisions and recommendations.

Citing Articles

The Prognostic Significance of Postoperative Adjuvant Chemotherapy in the Population Aged 75 Years and Older with Stage II-III Colorectal Cancer: A Retrospective Multi-Center Cohort Study.

Liu L, Pang X, Zhao K, Chen Y, Li Y, You R Int J Gen Med. 2023; 16:3311-3322.

PMID: 37554705 PMC: 10406118. DOI: 10.2147/IJGM.S420024.

Optimizing the management of elderly colorectal surgery patients.

Tan K, Konishi F, Tan L, Chin W, Ong H, Tan P Surg Today. 2010; 40(11):999-1010.

PMID: 21046496 DOI: 10.1007/s00595-010-4354-5.

References

Sargent D, Goldberg R, JACOBSON S, Macdonald J, Labianca R, Haller D . A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001; 345(15):1091-7. DOI: 10.1056/NEJMoa010957. View

Muss H, Biganzoli L, Sargent D, Aapro M . Adjuvant therapy in the elderly: making the right decision. J Clin Oncol. 2007; 25(14):1870-5. DOI: 10.1200/JCO.2006.10.3457. View

Koh P, Seow-Choen F . Multicentre prospective randomized trials are not always relevant to surgeons. ANZ J Surg. 2006; 76(5):286-7. DOI: 10.1111/j.1445-2197.2006.03709.x. View

Neugut A, Matasar M, Wang X, McBride R, Jacobson J, Tsai W . Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol. 2006; 24(15):2368-75. DOI: 10.1200/JCO.2005.04.5005. View

Arora A, Potter J . Older patients with colon cancer: is adjuvant chemotherapy safe and effective?. J Am Geriatr Soc. 2003; 51(4):567-9. DOI: 10.1046/j.1532-5415.2003.51169.x. View

Sundararajan V, Mitra N, Jacobson J, Grann V, Heitjan D, Neugut A . Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med. 2002; 136(5):349-57. DOI: 10.7326/0003-4819-136-5-200203050-00007. View

Francini G, Petrioli R, Lorenzini L, Mancini S, ARMENIO S, Tanzini G . Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology. 1994; 106(4):899-906. DOI: 10.1016/0016-5085(94)90748-x. View

Oconnell M, Laurie J, Kahn M, Fitzgibbons Jr R, Erlichman C, Shepherd L . Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol. 1998; 16(1):295-300. DOI: 10.1200/JCO.1998.16.1.295. View

. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995; 345(8955):939-44. View

10.

Laurie J, MOERTEL C, Fleming T, Wieand H, Leigh J, Rubin J . Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989; 7(10):1447-56. DOI: 10.1200/JCO.1989.7.10.1447. View

11.

Iwashyna T, Lamont E . Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol. 2002; 20(19):3992-8. DOI: 10.1200/JCO.2002.03.083. View

12.

Mano M, Duhoux F . Colon cancer: update on adjuvant therapy. Clin Colorectal Cancer. 2008; 7(3):178-83. DOI: 10.3816/CCC.2008.n.023. View

13.

Zaniboni A, Labianca R, Marsoni S, Torri V, Mosconi P, Grilli R . GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma--long term results and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione.... Cancer. 1998; 82(11):2135-44. DOI: 10.1002/(sici)1097-0142(19980601)82:11<2135::aid-cncr7>3.0.co;2-u. View

14.

Jessup J, Stewart A, Greene F, Minsky B . Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005; 294(21):2703-11. DOI: 10.1001/jama.294.21.2703. View

15.

Retornaz F, Monette J, Batist G, Monette M, Sourial N, Small D . Usefulness of frailty markers in the assessment of the health and functional status of older cancer patients referred for chemotherapy: a pilot study. J Gerontol A Biol Sci Med Sci. 2008; 63(5):518-22. DOI: 10.1093/gerona/63.5.518. View

16.

Hata F, Sasaki K, Hirata K, Yamamitsu S, Shirasaka T . Efficacy of a continuous venous infusion of fluorouracil and daily divided dose cisplatin as adjuvant therapy in resectable colorectal cancer: a prospective randomized trial. Surg Today. 2008; 38(7):623-32. DOI: 10.1007/s00595-007-3689-z. View